First in human study to assess safety, pharmacokinetics and pharmacodynamics of BMS-962212, a direct, reversible, small molecule factor XIa inhibitor in non-Japanese and Japanese healthy subjects.
| Author | |
|---|---|
| Abstract | :
To assess the safety, pharmacokinetics (PK) and pharmacodynamics (PD) of BMS-962212, a first-in-class Factor XIa inhibitor, in Japanese and non-Japanese healthy subjects. |
| Year of Publication | :
2018
|
| Journal | :
British journal of clinical pharmacology
|
| Date Published | :
2018
|
| ISSN Number | :
0306-5251
|
| URL | :
http://dx.doi.org/10.1111/bcp.13520
|
| DOI | :
10.1111/bcp.13520
|
| Short Title | :
Br J Clin Pharmacol
|
| Download citation |